By Kimberly N. Alleyne
Stroudsburg, Pa., Aug. 30 - ISTO Technologies Inc. announced Wednesday the completion of a $10.8 million financing package, which includes equity and development funds.
Zimmer Holdings Inc. led the financing round and other investors include Alafi
Capital Co. LLC, Life Science Partners and Mid-America Transplant Services.
The company is developing cell-based therapies that team with the body's resources to heal, regenerate and restore full function to damaged cartilage.
ISTO Technologies, Inc. is headquartered in St. Louis.
| Issuer: | ISTO Technologies Inc.
|
| Issue: | Equity, development financing
|
| Amount: | $10.8 million
|
| Investors: | Zimmer Holdings Inc. (lead), Alafi Capital Co. LLC, Life Science Partners and Mid-America Transplant Services
|
| Announcement date: | Aug. 31
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
